New diagnostics for multi-drug resistant tuberculosis in India: Innovating control and controlling innovation
Author:
- 6 February 2012
- journal article
- research article
- Published by Springer Nature in BioSocieties
- Vol. 7 (1) , 50-71
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Mismanagement of tuberculosis in India: Causes, consequences, and the way forwardHypothesis, 2011
- Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?PLOS ONE, 2010
- Embodied Interventions—Interventions on Bodies: Experiments in Practices of Science and Technology Studies and Hemophilia CareScience, Technology, & Human Values, 2009
- POST-PASTEURIAN CULTURES: The Microbiopolitics of Raw-Milk Cheese in the United StatesCultural Anthropology, 2008
- Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical FirmsTechnology Analysis & Strategic Management, 2007
- Seven habits of highly effective global public–private health partnerships: Practice and potentialSocial Science & Medicine, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006
- Progress towards improved tuberculosis diagnostics for developing countriesThe Lancet, 2006
- Treatment of tuberculosis by private general practitioners in IndiaTubercle, 1991